Clinical Trial Update: AVE7688 in Patients With Mild to Moderate Blood Pressure [Phase 2, Phase 3]

View source ↗

Summary

Reports the completion of Phase 2 and Phase 3 clinical trials of AVE7688 in patients with hypertension. Sponsored by Sanofi.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• AVE7688

Snippet

Sponsor: Sanofi | Conditions: Hypertension | Phase 2, Phase 3 | Status: COMPLETED